7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 
      
                               
      revenues
                               
      pharmacy revenues
    56,054,000,000 53,649,000,000 48,633,000,000 33,855,250,000 48,284,000,000 45,101,000,000 42,036,000,000 25,159,750,000 34,531,000,000 33,964,000,000 32,144,000,000 33,135,000,000 32,762,000,000 31,972,000,000 30,697,000,000 32,328,000,000 31,013,000,000 30,047,000,000 28,025,000,000 28,305,000,000 27,802,000,000 26,564,000,000 25,098,000,000 19,363,500,000 25,987,000,000 26,288,000,000 25,179,000,000 
      premiums
    9,081,000,000 9,156,000,000 12,736,000,000 8,623,250,000 11,436,000,000 11,454,000,000 11,603,000,000 8,265,500,000 10,998,000,000 11,039,000,000 11,025,000,000 9,547,000,000 9,586,000,000 10,426,000,000 10,356,000,000 10,342,000,000 10,275,000,000 10,323,000,000 10,214,000,000 10,699,000,000 10,682,000,000 10,406,000,000 10,840,000,000 7,427,250,000 9,935,000,000 9,803,000,000 9,971,000,000 
      fees and other revenues
    4,380,000,000 4,137,000,000 3,895,000,000 2,715,500,000 3,889,000,000 3,647,000,000 3,326,000,000 2,393,500,000 3,198,000,000 3,305,000,000 3,071,000,000 2,857,000,000 2,728,000,000 2,757,000,000 2,538,000,000 2,638,000,000 2,532,000,000 2,451,000,000 2,341,000,000 2,337,000,000 2,174,000,000 2,072,000,000 2,178,000,000 1,780,750,000 2,285,000,000 2,388,000,000 2,450,000,000 
      net investment income
    233,000,000 236,000,000 238,000,000 174,000,000 85,000,000 321,000,000 290,000,000 -854,000,000 321,000,000 278,000,000 277,000,000 212,000,000 204,000,000 325,000,000 414,000,000 380,000,000 468,000,000 310,000,000 391,000,000 371,000,000 297,000,000 223,000,000 353,000,000 258,750,000 349,000,000 340,000,000 346,000,000 
      total revenues
    69,748,000,000 67,178,000,000 65,502,000,000 -180,977,000,000 63,694,000,000 60,523,000,000 57,255,000,000 -143,613,000,000 49,048,000,000 48,586,000,000 46,517,000,000 45,751,000,000 45,280,000,000 45,480,000,000 44,005,000,000 45,688,000,000 44,288,000,000 43,131,000,000 40,971,000,000 41,712,000,000 40,955,000,000 39,265,000,000 38,469,000,000 38,245,000,000 38,556,000,000 38,819,000,000 37,946,000,000 
      benefits and expenses
                               
      pharmacy and other service costs
    55,530,000,000 53,268,000,000 48,398,000,000 33,372,000,000 47,565,000,000 44,492,000,000 41,431,000,000 24,635,000,000 33,639,000,000 33,442,000,000 31,459,000,000 32,094,000,000 31,777,000,000 31,150,000,000 29,813,000,000 31,247,000,000 30,070,000,000 29,001,000,000 27,235,000,000 27,059,000,000 26,624,000,000 25,611,000,000 24,190,000,000 18,391,250,000 24,552,000,000 24,963,000,000 24,050,000,000 
      medical costs and other benefit expenses
    7,842,000,000 7,749,000,000 10,498,000,000 7,120,500,000 9,527,000,000 9,515,000,000 9,440,000,000 6,751,750,000 8,927,000,000 9,034,000,000 9,046,000,000 7,992,000,000 7,754,000,000 8,192,000,000 8,268,000,000 8,743,000,000 8,330,000,000 8,484,000,000 8,005,000,000 8,847,000,000 8,429,000,000 7,112,000,000 8,322,000,000 5,732,500,000 7,734,000,000 7,576,000,000 7,620,000,000 
      selling, general and administrative expenses
    3,362,000,000 3,433,000,000 4,213,000,000 -10,965,000,000 3,590,000,000 3,684,000,000 3,705,000,000 -10,758,000,000 3,788,000,000 3,434,000,000 3,538,000,000 3,483,000,000 3,148,000,000 3,256,000,000 3,299,000,000 3,662,000,000 3,093,000,000 2,996,000,000 3,279,000,000 3,966,000,000 3,301,000,000 3,407,000,000 3,398,000,000 2,524,000,000 3,413,000,000 3,380,000,000 3,303,000,000 
      amortization of acquired intangible assets
    436,000,000 422,000,000 422,000,000 319,750,000 436,000,000 420,000,000 423,000,000 342,000,000 454,000,000 455,000,000 459,000,000 457,000,000 460,000,000 501,000,000 458,000,000 499,000,000 501,000,000 503,000,000 495,000,000 495,000,000 493,000,000 496,000,000 498,000,000 -2,214,002,949 734,000,000 737,000,000 743,000,000 
      total benefits and expenses
    67,170,000,000 64,872,000,000 63,531,000,000 43,557,000,000 61,118,000,000 58,111,000,000 54,999,000,000 34,418,750,000 46,808,000,000 46,365,000,000 44,502,000,000 44,026,000,000 43,139,000,000 43,099,000,000 41,838,000,000 44,151,000,000 41,994,000,000 40,984,000,000 39,014,000,000 40,367,000,000 38,847,000,000 36,626,000,000 36,408,000,000 27,201,250,000 36,433,000,000 36,656,000,000 35,716,000,000 
      income from operations
    2,578,000,000 2,306,000,000 1,971,000,000 -6,763,000,000 2,576,000,000 2,412,000,000 2,256,000,000 -5,940,000,000 2,240,000,000 2,221,000,000 2,015,000,000 1,725,000,000 2,141,000,000 2,381,000,000 2,167,000,000 1,537,000,000 2,294,000,000 2,147,000,000 1,957,000,000 1,345,000,000 2,108,000,000 2,639,000,000 2,061,000,000 1,629,000,000 2,123,000,000 2,163,000,000 2,230,000,000 
      yoy
    0.08% -4.39% -12.63% 13.86% 15.00% 8.60% 11.96% -444.35% 4.62% -6.72% -7.01% 12.23% -6.67% 10.90% 10.73% 14.28% 8.82% -18.64% -5.05% -17.43% -0.71% 22.01% -7.58%     
      qoq
    11.80% 17.00% -129.14% -362.54% 6.80% 6.91% -137.98% -365.18% 0.86% 10.22% 16.81% -19.43% -10.08% 9.88% 40.99% -33.00% 6.85% 9.71% 45.50% -36.20% -20.12% 28.04% 26.52% -23.27% -1.85% -3.00%  
      operating margin %
                               
      interest expense and other
    -347,000,000 -337,000,000 -362,000,000 -315,000,000 -376,000,000 -375,000,000 -322,000,000 -271,500,000 -365,000,000 -363,000,000 -358,000,000 -324,000,000 -304,000,000 -301,000,000 -299,000,000 -293,000,000 -303,000,000 -298,000,000 -314,000,000 -337,000,000 -336,000,000 -374,000,000 -391,000,000 -322,750,000 -411,000,000 -428,000,000 -452,000,000 
      gain on sale of businesses
    38,000,000  41,000,000     -5,250,000 -21,000,000   -73,000,000 1,735,000,000               
      net investment gains
    26,000,000 52,000,000                          
      income before income taxes
    2,295,000,000 2,021,000,000 1,648,000,000 -4,169,000,000 1,192,000,000 1,989,000,000 79,000,000 -6,239,000,000 1,840,000,000 1,884,000,000 1,601,000,000 1,328,000,000 3,491,000,000 1,985,000,000 1,549,000,000 1,312,000,000 2,059,000,000 1,898,000,000 1,513,000,000 5,378,000,000 1,804,000,000 2,289,000,000 1,397,000,000 -5,308,993,430 1,763,000,000 1,758,000,000 1,788,000,000 
      total income taxes
    322,000,000 389,000,000 239,000,000 254,500,000 367,000,000 360,000,000 291,000,000 265,000,000 391,000,000 374,000,000 295,000,000 130,000,000 713,000,000 413,000,000 351,000,000 179,000,000 424,000,000 422,000,000 342,000,000 1,236,000,000 406,000,000 529,000,000 208,000,000 293,250,000 409,000,000 348,000,000 416,000,000 
      net income
    1,973,000,000 1,632,000,000 1,409,000,000 560,500,000 825,000,000 1,629,000,000 -212,000,000 1,066,250,000 1,449,000,000 1,510,000,000 1,306,000,000 1,198,000,000 2,778,000,000 1,572,000,000 1,198,000,000 1,133,000,000 1,635,000,000 1,476,000,000 1,171,000,000 4,142,000,000 1,398,000,000 1,760,000,000 1,189,000,000 1,034,000,000 1,354,000,000 1,410,000,000 1,372,000,000 
      yoy
    139.15% 0.18% -764.62% -47.43% -43.06% 7.88% -116.23% -11.00% -47.84% -3.94% 9.02% 5.74% 69.91% 6.50% 2.31% -72.65% 16.95% -16.14% -1.51% 300.58% 3.25% 24.82% -13.34%     
      qoq
    20.89% 15.83% 151.38% -32.06% -49.36% -868.40% -119.88% -26.41% -4.04% 15.62% 9.02% -56.88% 76.72% 31.22% 5.74% -30.70% 10.77% 26.05% -71.73% 196.28% -20.57% 48.02% 14.99% -23.63% -3.97% 2.77%  
      net income margin %
                               
      less: net income attributable to noncontrolling interests
    105,000,000 100,000,000 86,000,000 58,000,000 86,000,000 81,000,000 65,000,000 32,500,000 41,000,000 50,000,000 39,000,000 29,000,000 21,000,000 13,000,000 15,000,000 17,000,000 14,000,000 9,000,000 10,000,000 7,000,000 10,000,000 6,000,000 8,000,000 2,250,000 3,000,000 2,000,000 4,000,000 
      shareholders' net income
    1,868,000,000 1,532,000,000 1,323,000,000    -277,000,000 1,029,000,000 1,408,000,000 1,460,000,000 1,267,000,000 1,169,000,000 2,757,000,000 1,559,000,000 1,183,000,000 1,116,000,000 1,621,000,000 1,467,000,000 1,161,000,000         
      shareholders' net income per share
                               
      basic
    7.02 5.76 4.88 1.783 2.65 5.51 -0.97 3.508 4.79 4.96 4.28 3.94 9.07 4.95 3.71             
      diluted
    6.98 5.71 4.85 1.763 2.63 5.45 -0.97 3.473 4.74 4.92 4.24 3.88 8.97 4.9 3.68             
      net investment losses
      -2,000,000                         
      loss on sale of businesses
       -26,500,000 -87,000,000  -19,000,000                     
      net realized investment losses
       -701,250,000 -921,000,000  -1,836,000,000 -11,000,000 -14,000,000  -56,000,000                 
      shareholders’ net income
       502,500,000 739,000,000 1,548,000,000              1,080,750,000 1,388,000,000 1,754,000,000 1,181,000,000 977,000,000 1,351,000,000 1,408,000,000 1,368,000,000 
      net realized investment gains
         -48,000,000    26,000,000   -81,000,000 -95,000,000 -319,000,000 68,000,000 68,000,000 59,000,000 1,000,000 167,000,000 32,000,000 38,000,000 -88,000,000 21,000,000 51,000,000 23,000,000 10,000,000 
      debt extinguishment costs
                     -10,000,000 -131,000,000   -14,000,000 -185,000,000     
      shareholders’ net income per share
                               
      basic
                   3.11 4.84 4.3 3.33 11.4 3.81 4.77 3.19 2.735 3.6 3.73 3.61 
      diluted
                   3.08 4.8 4.25 3.3 11.3 3.78 4.73 3.15 2.708 3.57 3.7 3.56 
      the accompanying notes to the consolidated financial statements (unaudited) are an integral part of these statements.
                               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.